Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-139352

Options or other derivatives

  • Director acquired 186,142 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Thompson Peter A. Director 2016-08-11 Grant or award · Option to purchase Ordinary Shares +186,142 186,142 D
Loading xslF345X03/a4.xml…